The role of levocarnitine in the systemic therapy of patients of different profile of patients on chronic hemodialysis
Journal Title: Нирки - Year 2014, Vol 1, Issue 7
Abstract
the paper presents the pharmacological characteristics of L-carnitine and evaluation of the effectiveness of its application in nephrology practice. Discussed the evidence of the use of levocarnitine for chronic kidney disease and chronic renal failure
Authors and Affiliations
A. M. Ivanova, O. O. Bogomolets
Keywords
Related Articles
- EP ID EP225233
- DOI -
- Views 103
- Downloads 0
Renin-Angiotensin System Blockers and Renal Functional Reserve. Is There a Limit of Renoprotection?
Renin-angiotensin system (RAS) blockers (angiotensin converting enzyme inhibitors, angiotensin receptor blockers, direct renin inhibitor) have a renoprotective effect in the presence of preserved glomerular filtration ra...
International Course of Postgraduate Education REENA™ «Clinical Case in Nephrology»
The review of key lectures which were presented on the international course of postgraduate education REENA™ “Clinical case in nephrology” on September’16th, 2016 in Irpen, Ukraine, is presented in the article.
Heart rate variability in children with chronic pyelonephritis and I–III stages of chronic kidney disease
Background. Assessment of heart rate variability allows us to get an idea about the functional state of the autonomic nervous system and to identify changes in autonomic homeostasis in children. The purpose was to study...
Chronic kidney disease and anemia: application of ferrous bisglycinate chelate for correction of iron deficiency in patients with chronic kidney disease
Anemia is a component of chronic kidney disease, having erythropoietin- and iron deficiency nature. 2012 KDIGO guidelines determine anemia as a hemoglobin concentration < 120 g/l in women and < 130 g/l in men. An iron de...
Calcium and Phosphorus Metabolism in Chronic Kidney Disease
.